Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Progress in neurobiology

• Publication date

  1999-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0301-0082(98)00075-6PMID 10321796
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of sodium valproate on motor function regulated by the activation of GABA receptors

  2004cited by this paper
• Effect of sodium valproate on mania

  2004cited by this paper
• Valproate and sodium currents in cultured hippocampal neurons

  2004cited by this paper
• Absorption, distribution, and excretion

  1999cited by this paper
• Chemistry and biotransformation

  1999cited by this paper
• Valproate in the treatment of headache

  1999cited by this paper
• Comparison of Effects of Valproate and Trans‐2‐en‐Valproate on Different Forms of Epileptiform Activity in Rat Hippocampal and Temporal Cortex Slices

  1998cited by this paper
• New visions in the pharmacology of anticonvulsion.

  1998cited by this paper
• Electrophysiologic Analysis of the Actions of Valproate on Pyramidal Neurons in the Rat Hippocampal Slice

  1998cited by this paper
• Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers.

  1998cited by this paper
• The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates.

  1997cited by this paper
• Effects of subchronic treatment with valproate on L-5-HTP-induced cortisol responses in mania: evidence for increased central serotonergic neurotransmission.

  1997cited by this paper
• Preventing post-traumatic epilepsy after brain injury: weighing the costs and benefits of anticonvulsant prophylaxis.

  1997cited by this paper
• Animal models of intractable epilepsy.

  1997cited by this paper
• Brain microdialysis of GABA and glutamate: What does it signify?

  1997cited by this paper
• Possible Mechanisms of Valproate in Migraine Prophylaxis

  1997cited by this paper
• Clinical Significance of Animal Seizure Models and Mechanism of Action Studies of Potential Antiepileptic Drugs

  1997cited by this paper
• Trans-2-en-valproic acid limits action potential firing frequency in mouse central neurons in cell culture.

  1997cited by this paper
• Effects of valproate on amino acid and monoamine concentrations in striatum of audiogenic seizure-prone Balb/c mice.

  1996cited by this paper
• Valproic acid differs in its in vitro effect on glutamic acid decarboxylase activity in neonatal and adult rat brain.

  1996cited by this paper
• Binding of a valproate metabolite to the trifunctional protein of fatty acid oxidation

  1996cited by this paper
• A comparison of the effects of valproate and its major active metabolite E-2-en-valproate on single unit activity of substantia nigra pars reticulata neurons in rats.

  1996cited by this paper
• Uptake of valproic acid into rat brain is mediated by a medium-chain fatty acid transporter.

  1996cited by this paper
• The role of the piriform cortex in kindling.

  1996cited by this paper
• Valproate and its major metabolite E-2-en-valproate induce different effects on behaviour and brain monoamine metabolism in rats.

  1996cited by this paper
• Does Antiepileptic Drug Therapy Prevent the Development of “Chronic” Epilepsy?

  1996cited by this paper
• Effects of methysticin on three different models of seizure like events studied in rat hippocampal and entorhinal cortex slices

  1995cited by this paper
• Differential effects of phenytoin and sodium valproate on seizure-induced changes in gamma-aminobutyric acid and glutamate release in vivo.

  1995cited by this paper
• Comparison of Anticonvulsant Efficacy of Valproate During Prolonged Treatment with One and Three Daily Doses or Continuous (“Controlled Release”) Administration in a Model of Generalized Seizures in Rats

  1995cited by this paper
• Paroxysmal epileptiform discharges in temporal lobe slices after prolonged exposure to low magnesium are resistant to clinically used anticonvulsants.

  1995cited by this paper
• Review of the Mechanisms of Action of Antiepileptic Drugs

  1995cited by this paper
• Monotherapy versus Polytherapy in Epilepsy

  1995cited by this paper
• Distribution of Unsaturated Metabolites of Valproate in Human and Rat Brain‐Pharmacologic Relevance?

  1995cited by this paper
• Platelet and brain GABA-transaminase and monoamine oxidase activities in patients with complex partial seizures.

  1995cited by this paper
• GABA and mood disorders: a brief review and hypothesis.

  1995cited by this paper
• Strategies for the Development of Drugs for Pharmacoresistant Epilepsies

  1994cited by this paper
• Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?

  1994cited by this paper
• Sodium valproate induced alterations in monoamine levels in different regions of the rat brain.

  1994cited by this paper
• Valproic Acid

  1994cited by this paper
• Valproic acid suppresses the synaptic response mediated by the NMDA receptors in rat amygdalar slices.

  1994cited by this paper
• Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.

  1994cited by this paper
• Differential effects of vigabatrin, γ-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma

  1994cited by this paper
• Pharmacological characterization of phenytoin-resistant amygdala-kindled rats, a new model of drug-resistant partial epilepsy.

  1993cited by this paper
• The MARCKS family of cellular protein kinase C substrates.

  1993cited by this paper
• Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain

  1993cited by this paper
• Valproate (VPA) Metabolites in Various Clinical Conditions of Probable VPA‐Associated Hepatotoxicity

  1993cited by this paper
• Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. II. Influence of phenobarbital comedication.

  1993cited by this paper
• Effects of valproate on early and late potassium currents of single neurons.

  1993cited by this paper
• Antiepileptic Drug Mechanisms of Action

  1993cited by this paper
• Consequences of Epileptic Activity in vitro

  1993cited by this paper
• Evidence of stimulation of the gamma-aminobutyric acid shunt by valproate and E-delta 2-valproate in neonatal rat brain.

  1993cited by this paper
• In vivo administration of valproate reduces the nerve terminal (synaptosomal) activity of GABA aminotransferase in discrete brain areas of rats.

  1993cited by this paper
• Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. III. Influence of fasting.

  1993cited by this paper
• Pharmacological, toxicological and neurochemical effects of delta 2(E)-valproate in animals.

  1992cited by this paper
• The enantioselective teratogenicity of 2-n-propyl-4-pentynoic acid (4-yn-VPA) is due to stereoselective intrinsic activity and not differences in pharmacokinetics.

  1992cited by this paper
• Valproic acid treatment of experimental status epilepticus.

  1992cited by this paper
• Intravenous valproate: onset and duration of anticonvulsant activity against a series of electroconvulsions in comparison with diazepam and phenytoin.

  1992cited by this paper
• GABA receptor alterations after chronic lithium administration. Comparison with carbamazepine and sodium valproate.

  1992cited by this paper
• Idiosyncratic Reactions to Valproate: Clinical Risk Patterns and Mechanisms of Toxicity

  1992cited by this paper
• Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. I. Biochemical, histopathological and pharmacokinetic studies.

  1992cited by this paper
• Characterization of extracellular GABA in the substantia nigra reticulata by means of brain microdialysis

  1992cited by this paper
• Effects of Valproate in a Model Nervous System (Buccal Ganglia of Helix Pomatia): I. Antiepileptic Actions

  1992cited by this paper
• The effect of sodium valproate on extracellular GABA and other amino acids in the rat ventral hippocampus: an in vivo microdialysis study.

  1992cited by this paper
• Interactions between valproate, glutamate, aspartate, and GABA with respect to uptake in astroglial primary cultures

  1992cited by this paper
• 3-alkyl GABA and 3-alkylglutamic acid analogues: two new classes of anticonvulsant agents.

  1992cited by this paper
• Effects of valproate in a model nervous system (buccal ganglia of Helix pomatia): I. Antiepileptic actions.

  1992cited by this paper
• Regional Effects of Sodium Valproate on Extracellular Concentrations of 5‐Hydroxytryptamine, Dopamine, and Their Metabolites in the Rat Brain: An In Vivo Microdialysis Study

  1992cited by this paper
• On the development of alternative antiepileptic drugs

  1991cited by this paper
• Comparative Pharmacodynamics and Brain Distribution of E‐δ2‐Valproate and Valproate in Rats

  1991cited by this paper
• Comparative pharmacodynamics and brain distribution of E-delta 2-valproate and valproate in rats.

  1991cited by this paper
• Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms.

  1991cited by this paper
• Effects of pharmacological manipulation of GABAergic neurotransmission in a new mutant hamster model of paroxysmal dystonia.

  1991cited by this paper
• Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilepsy

  1991cited by this paper
• Anticonvulsant Drug Mechanisms

  1991cited by this paper
• “In vivo” administration of valproate decreases t-[35S]butylbicyclophosphorothionate binding in the rat brain

  1991cited by this paper
• Kindling as a model of drug-resistant partial epilepsy: selection of phenytoin-resistant and nonresistant rats.

  1991cited by this paper
• Valproate suppresses N-methyl-D-aspartate-evoked, transient depolarizations in the rat neocortex in vitro.

  1991cited by this paper
• Evaluation and treatment of seizures.

  1990cited by this paper
• Late low magnesium-induced epileptiform activity in rat entorhinal cortex slices becomes insensitive to the anticonvulsant valproic acid.

  1990cited by this paper
• Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds.

  1990cited by this paper
• Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neurons.

  1990cited by this paper
• Phaclofen increases gaba release from valproate treated rats

  1990cited by this paper
• The anticonvulsant valproic acid concentrates in the olfactory bulb: selective laminar localization.

  1990cited by this paper
• Neurophysiological and biochemical changes evoked by valproic acid in the central nervous system.

  1990cited by this paper
• The evaluation and treatment of seizures.

  1990cited by this paper
• Development of the oculomotor and trochlear nuclei in the Xenopus toad.

  1990cited by this paper
• Inactivation of beef brain alpha-ketoglutarate dehydrogenase complex by valproic acid and valproic acid metabolites. Possible mechanism of anticonvulsant and toxic actions.

  1990cited by this paper
• Characterization of ethosuximide reduction of low‐threshold calcium current in thalamic neurons

  1989cited by this paper
• [Structural bases of the teratogenic effects of the antiepileptic valproic acid. 2-n-propyl-4-pentenic acid, the first structural analogue with significantly higher teratogenic action than VPA].

  1989cited by this paper
• Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy.

  1989cited by this paper
• Neuronal activity, amino acid concentration and amino acid release in the substantia nigra of the rat after sodium valproate.

  1989cited by this paper
• Failure of the antiepileptic drug valproic acid to modify synaptic and non-synaptic responses of CA1 hippocampal pyramidal cells maintained 'in vitro'.

  1989cited by this paper
• Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment.

  1989cited by this paper
• Valproate enhances GABA turnover in the substantia nigra.

  1989cited by this paper
• Antiepileptic Drug Actions

  1989cited by this paper
• 'GABA shift' in vivo: enhancement of benzodiazepine binding in vivo by modulation of endogenous GABA.

  1988cited by this paper
• Valproate enhances GABA-A mediated inhibition of locus coeruleus neurones in vitro

  1988cited by this paper
• Is the anticonvulsant mechanism of valproate linked to its interaction with the cerebral gamma-hydroxybutyrate system?

  1988cited by this paper
• Suppression of preoptic GABA release caused by push-pull-perfusion with sodium valproate

  1988cited by this paper
• gamma-Hydroxybutyrate model of generalized absence seizures: further characterization and comparison with other absence models.

  1988cited by this paper

• Therapeutic Potential of Cuscutae Semen and Rehmanniae Radix Preparata in Age-Related Central Hearing Loss Associated with Gad1 Regulation.

  2026cites this paper
• Digestive Dimensions of Autism: A Multiscale Exploration of Gut-Brain Interactions

  2025cites this paper
• A precision approach to therapeutic drug monitoring of valproate to evaluate markers of toxicity

  2025cites this paper
• Digestive Neurobiology in Autism: From Enteric and Central Nervous System Interactions to Shared Genetic Pathways

  2025cites this paper
• Sodium‐Coupled Monocarboxylate Absorption in the Airway Epithelium Is Facilitated by the SLC5A8 Co‐Transporter

  2025cites this paper
• Integrated analysis of metabolome and microbiome in a mouse model of sodium valproate-induced autism

  2025cites this paper
• Lingual Dyskinesia Developing after the First Dose of Methylphenidate Treatment in a Child with Neurodevelopmental Disorders: Genetic Predispositions

  2025cites this paper
• The Pharmacokinetic and Pharmacodynamic Relationship of Clinically Used Antiseizure Medications in the Maximal Electroshock Seizure Model in Rodents

  2025cites this paper
• Epilepsy: Insights into Pathophysiology, Therapeutic Approaches, and the Emerging Role of Phytochemicals

  2025cites this paper
• Valproate induces non-hyperammonemic encephalopathy below a standard serum concentration range: A case report

  2025cites this paper
• Automated detection of complex zebrafish seizure behavior at scale

  2025cites this paper
• BEHAVIORAL AND TRANSCRIPTOMIC EFFECTS OF A NOVEL CANNABINOID ON A RAT VALPROIC ACID MODEL OF AUTISM.

  2025cites this paper
• Acute dose-related effect of antiseizure medications on open field exploration of male rats with established epilepsy.

  2025cites this paper
• EGR1-mediated repression of HDAC2 regulates BDNF-dependent kindling development in a mouse model of pentylenetetrazol-induced epilepsy.

  2025cites this paper
• Valproic acid as a therapeutic scaffold: Advances in structural modification and drug design.

  2025cites this paper
• Established and emerging GABAA receptor pharmacotherapy for epilepsy

  2024cites this paper
• The antiseizure medication valproate increases hemichannel activity found in brain cells, which could worsen disease outcomes

  2024cites this paper
• Heterogeneous brain distribution of bumetanide following systemic administration in rats

  2024influential citation
• The Role of Epigenetics and Contributing Impact of Stress, Multigenerational, and Developmental Factors in Opiate Addiction

  2024cites this paper
• Determination of Antiepileptics in Biological Samples—A Review

  2024cites this paper
• Valproic acid attenuates the severity of astrogliosis in the hippocampus of animal models of temporal lobe epilepsy

  2024cites this paper
• Low intensity transcranial ultrasound stimulation induces hemodynamic responses through neurovascular coupling

  2024cites this paper
• Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on hippocampal long-term potentiation at perforant pathway-dentate gyrus synapses in prenatal valproic acid-induced rat model of autism

  2024cites this paper
• Cardiovascular developmental hazards of valproic acid in zebrafish.

  2024cites this paper
• Effect of patients in-use and accelerated stability conditions on quality attributes and pharmacokinetic profile of four FDA approved extended-release anti-epileptic-drug products.

  2024cites this paper
• The Interactions of Resveratrol and Sodium Valproate on Penicillin-Induced Epilepsy Model: Electrophysiological and Molecular Study

  2024cites this paper
• Long-lasting antiseizure effects of chronic intrasubthalamic convection-enhanced delivery of valproate.

  2023cites this paper
• Translational Considerations in the Development of Intranasal Treatments for Epilepsy

  2023cites this paper
• Transient plasticity response is regulated by histone deacetylase inhibitor in oxygen–glucose deprivation condition

  2023cites this paper
• Molecular Mechanisms of Valproic Acid Action on Signalling Systems and Brain Functions

  2023cites this paper
• Culprits of Medication-Induced Telogen Effluvium, Part 1.

  2023cites this paper
• Fundamental Neurochemistry Review: GABAA receptor neurotransmission and epilepsy: Principles, disease mechanisms and pharmacotherapy

  2023cites this paper
• Cross-reactivity between histone demethylase inhibitor valproic acid and DNA methylation in glioblastoma cell lines

  2022cites this paper
• Schizophrenia, Bipolar and Major Depressive Disorders: Overview of Clinical Features, Neurotransmitter Alterations, Pharmacological Interventions, and Impact of Oxidative Stress in the Disease Process.

  2022cites this paper
• Effects of Low- and High-Dose Valproic Acid and Lamotrigine on the Heart in Female Rats

  2022cites this paper
• Neurobehavioral Differences of Valproate and Risperidone on MK-801 Inducing Acute Hyperlocomotion in Mice

  2022cites this paper
• Bioactivity of Ionic Liquids Based on Valproate in SH-SY5Y Human Neuroblastoma Cell Line

  2022cites this paper
• Epigenetic regulation of GABAergic differentiation in the developing brain

  2022cites this paper
• Protective effects of L-carnitine against valproic acid-induced memory impairment and anxiety-like behavior in adult rat.

  2022cites this paper
• Impairment in social interaction and hippocampal long-term potentiation at perforant pathway-dentate gyrus synapses in a prenatal valproic acid-induced rat model of autism

  2022cites this paper
• Ketogenic diet prevents paclitaxel‐induced neuropathic nociception through activation of PPARγ signalling pathway and inhibition of neuroinflammation in rat dorsal root ganglion

  2021cites this paper
• Criss‐crossing autism spectrum disorder and adult neurogenesis

  2021cites this paper
• Gene Environment Interactions in the Etiology of Neural Tube Defects

  2021cites this paper
• Valproate selectively suppresses adolescent anabolic/androgenic steroid-induced aggressive behavior: implications for a role of hypothalamic γ-aminobutyric acid neural signaling

  2021cites this paper
• The role of neuronal apoptosis in Valproic Acid brain-related teratogenesis: a histochemical and immunohistochemical study in BALB/c mice

  2021cites this paper
• Experimental Serotonin Syndrome: Effects of GABA-ergic Medications and 5-HT2-Antagonists

  2021cites this paper
• Clinical Pharmacokinetics of Cannabinoids and Potential Drug-Drug Interactions.

  2021cites this paper
• Valproic Acid Leads to an Increase in ROS Generation by Inhibiting the Deacetylation of Mitochondrial SOD

  2021cites this paper
• Protective Effects of Anthocleista djalonensis Extracts against Pentylenetetrazole-Induced Epileptic Seizures and Neuronal Cell Loss: Role of Antioxidant Defense System

  2021cites this paper
• Gene expression profiles of multiple brain regions in rats differ between developmental and postpubertal exposure to valproic acid

  2021cites this paper
• PGPM_A_329594 1141..1150

  2021cites this paper
• Non‐hyperammonaemia valproate‐induced encephalopathy: A case report

  2021cites this paper
• Investigation of the risk of valproic acid–induced tremor: clinical, neuroimaging, and genetic factors

  2021cites this paper
• The effects of valproate on serum leptin, insulin, and lipid levels in epileptic children

  2021cites this paper
• Long Non-coding RNAs and Circular RNAs: Insights Into Microglia and Astrocyte Mediated Neurological Diseases

  2021cites this paper
• Migraine

  2021cites this paper
• Genetic Polymorphism of GABRG2 rs211037 is Associated with Drug Response and Adverse Drug Reactions to Valproic Acid in Chinese Southern Children with Epilepsy

  2021cites this paper
• Unconditioned and learned morphine tolerance influence hippocampal-dependent short-term memory and the subjacent expression of GABA-A receptor alpha subunits

  2021cites this paper
• Mechanisms of action of currently used antiseizure drugs.

  2020cites this paper
• Levetiracetam Reduced the Basal Excitability of the Dentate Gyrus without Restoring Impaired Synaptic Plasticity in Rats with Temporal Lobe Epilepsy

  2020cites this paper
• Electrophysiological basis for antiepileptic drugs in migraine prevention.

  2020cites this paper
• Characteristics of Post-Ictal Headaches in Patients with Epilepsy: a Longitudinal Study.

  2020cites this paper
• Alcohol Withdrawal Syndrome in Neurocritical Care Unit: Assessment and Treatment Challenges

  2020cites this paper
• Valproate Sodium Protects Blood Brain Barrier Integrity in Intracerebral Hemorrhage Mice

  2020cites this paper
• Control of neuronal excitability by GSK-3beta: epilepsy and beyond.

  2020cites this paper
• Role of environmental factors and epigenetics in autism spectrum disorders.

  2020cites this paper
• Polysaccharide valproates: Structure - property relationships in solution.

  2020cites this paper
• STUDY REGARDING THE DETERMINATION OF VALPROIC ACID SERUM LEVELS BY EMIT

  2020cites this paper
• Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome

  2020cites this paper
• Mood Stabilizers: Valproate

  2020cites this paper
• Contemporary Pharmacotherapeutics and the Management of Aggressive Behavior in an Adolescent Animal Model of Maladaptive Aggression

  2020cites this paper
• Interaction of Sodium Valproate With Low-Frequency Electrical Stimulation During Kindlingn

  2020cites this paper
• Altered expression of glutamatergic and GABAergic genes in the valproic acid-induced rat model of autism: a screening test.

  2020cites this paper
• CHAPTER 7

  2020cites this paper
• Does caffeine therapy improve cognitive impairments in valproic acid rat model of autism?

  2019cites this paper
• Stimulation of Vagus By Phenylephrine Increases the Efficiency and Safety of Antidepressants and Anti-Epileptics

  2019cites this paper
• Catalase C-262T Polymorphism Is a Risk Factor for Valproic Acid–Induced Abnormal Liver Function in Chinese Patients With Epilepsy

  2019cites this paper
• Randomized controlled trial of adjunctive Valproate for cognitive remediation in early course schizophrenia.

  2019cites this paper
• Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences

  2019cites this paper
• Complex Combination Pharmacotherapy for Bipolar Disorder: Knowing When Less Is More or More Is Better.

  2019cites this paper
• Clinical Trials of Repurposing Medicines in Acute Myeloid Leukemia: Limitations and Possibilities in the Age of Precision Therapy.

  2019cites this paper
• Programming Bugs: Microbiota and the Developmental Origins of Brain Health and Disease.

  2019cites this paper
• The multifaceted therapeutic potential of valproic acid beyond CNS axis

  2019cites this paper
• Depacon Infusion Therapy

  2019cites this paper
• Sodium Valproate Improves Skin Flap Survival via Gamma-Aminobutyric Acid and Histone Deacetylase Inhibitory System.

  2019cites this paper
• Comparison of the Chronic Anticonvulsant Activity and Safety of IEM-1913, Sodium Valproate, IEM-1676, and Memantine in Experiments on Rats

  2019cites this paper
• Epigenetics in Psychiatry

  2019cites this paper
• The role of gamma-aminobutyric acid in female depression

  2019cites this paper
• Chronic valproate treatment influences folliculogenesis and reproductive hormones with possible ameliorating role for folic acid in adult albino rats.

  2019cites this paper
• Chance, serendipity and antiepileptic drugs

  2019cites this paper
• Interactions of valproic acid with lipid membranes of 1,2-dimyristoyl-sn-glycero-3-phosphocholine.

  2019cites this paper
• SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients

  2019cites this paper
• ADME Processes in Pharmaceutical Sciences

  2018cites this paper
• Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?

  2018cites this paper
• Behavioral Mechanisms That Depend on Dopamine and Serotonin in Caenorhabditis elegans Interact With the Antipsychotics Risperidone and Aripiprazole

  2018cites this paper
• Comparison of the Chronic Anticonvulsant Activity and Safety of IEM-2062, Sodium Valproate, and Memantine in a Corasol Kindling Model in Rats

  2018cites this paper
• Evaluation of The Inter-Batch Variability of An Active Pharmaceutical Ingredient: Morphologic, Rheologic And Calorimetric Characterization

  2018cites this paper
• The valproic acid-induced rodent model of autism.

  2018cites this paper
• Anoxic Myoclonic Status Epilepticus

  2018cites this paper
• Molecularly imprinted based solid phase microextraction method for monitoring valproic acid in human serum and pharmaceutical formulations

  2018cites this paper